Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

Clinical trial NCT06780397 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06780397
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Melanoma, Stage II Melanoma Stage III Melanoma Stage IV

Start date: 2025-02-01
Primary completion: 2027-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.